| Aaron Klein, CPNP | |
|
8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 | |
| (503) 659-1694 | |
| (503) 659-8984 |
| Full Name | Aaron Klein |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | 8645 Se Sunnybrook Blvd Ste 200, Clackamas, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598200180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 201810561NP-PP (Oregon) | Secondary |
| 363LP0200X | Nurse Practitioner - Pediatrics | AP60997794 (Washington) | Primary |
| Entity Name | Seattle Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003319500 PECOS PAC ID: 9032021050 Enrollment ID: O20031211000532 |
News Archive
Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.
Sangart, Inc., today announced that enrollment was completed in a Phase IIa clinical study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. Complete study results are expected, after follow up of outcomes in these patients, in the second half of 2010.
After extensive planning, strategizing, and consulting, Capsule, the leading provider of medical device connectivity, has announced that they are expanding their marketing program to include social media. From Twitter, to Capsule's very own Facebook fan page, Capsule is ready to engage and gain new insights in order to better serve the clinical and HIT community.
Lucideon has invested in a new six station knee wear testing simulator, doubling its capacity to perform knee wear testing for orthopaedic implant manufacturers and taking the total investment in this service to over £1 Million across the group...
Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aaron Klein, CPNP 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 Ph: (503) 659-1694 | Aaron Klein, CPNP 8645 Se Sunnybrook Blvd Ste 200, Clackamas, OR 97015-6841 Ph: (503) 659-1694 |
News Archive
Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.
Sangart, Inc., today announced that enrollment was completed in a Phase IIa clinical study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. Complete study results are expected, after follow up of outcomes in these patients, in the second half of 2010.
After extensive planning, strategizing, and consulting, Capsule, the leading provider of medical device connectivity, has announced that they are expanding their marketing program to include social media. From Twitter, to Capsule's very own Facebook fan page, Capsule is ready to engage and gain new insights in order to better serve the clinical and HIT community.
Lucideon has invested in a new six station knee wear testing simulator, doubling its capacity to perform knee wear testing for orthopaedic implant manufacturers and taking the total investment in this service to over £1 Million across the group...
Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.
› Verified 8 days ago